A study by Providence CORE is among the first to explore the full continuum of patient engagement in an at-home colorectal cancer screening FIT kit program, from initial participation to sustained engagement and follow-up care. Findings could inform strategies to increase screening rates and early detection.

Back to CORE's website | CORE's blog stream
Colorectal cancer (CRC) is a growing cause of cancer-related death in the United States, and rates are rising among younger adults. Known as "the most preventable yet least prevented cancer," more than 90% of CRC cases are treatable when detected early. Yet up to 40% of eligible U.S. patients are behind on recommended screenings.
Past research suggests this gap may stem from barriers associated with colonoscopies. Colonoscopies are the gold standard for CRC screening, but they are invasive and require preparation, sedation, and transportation assistance.
More convenient options like at-home fecal immunochemical tests (FITs) could help more people catch and treat CRC early. However, effective screening requires more than a single test. Patients must complete a FIT kit annually and receive a colonoscopy if their FIT results are abnormal.
A recently published Providence CORE study is among the first to examine the full FIT CRC screening journey in a community setting, from initial FIT participation and continued annual screening (also known as persistency) to follow-up colonoscopy after an abnormal result. The findings offer insights into how patients engage with screening over time and highlight opportunities for FIT programs to increase screening rates across populations.
Learn more below or read the peer-reviewed paper in Scientific Reports.
Understanding patients’ FIT screening journeys
With funding from The Patrick and Catherine Weldon Donaghue Medical Research Foundation, researchers at Providence CORE analyzed data from 158,000 Providence health system patients. The study explored how patients engaged with the FIT program, from completing an initial screening, staying current with recommended testing (persistency), and obtaining follow-up care when needed.
Using electronic health records, the researchers evaluated how patients moved through each stage of the CRC cancer screening journey and examined screening patterns as well as disparities across patient populations.
The study highlights opportunities to improve outreach, strengthen long-term engagement, and maximize the effectiveness of FIT-based CRC screening.
Key Findings
CORE found that Providence’s program had a relatively high rate of engagement with an initial FIT kit. More than half of patients (59%) who were mailed a FIT participated in the test. That’s notably higher than the 30-40% screening rates reported in other U.S. studies. The researchers also cautioned that different measurement approaches may underpin this difference.
One of the study’s most promising findings was that those who completed an initial FIT were more likely to complete a second test the following year. This suggests that patients may be more willing to participate once they are familiar with FIT kits.
However, fewer than 60% of patients with an abnormal FIT received a colonoscopy at Providence within 12 months. This aligns with studies of other FIT programs and represents an industry-wide opportunity for improvement.
A concerning finding was that patients under 50 had the lowest rates of initial FIT engagement and among the lowest rates of continued screening (persistency). With CRC rising among younger adults, increasing screenings among this group is essential. On the plus side, patients under 50 who completed a FIT had among the highest rates of follow-up care engagement.
The study also found differences by race/ethnicity, language, type of healthcare coverage, and geography. For example:
- Patients 75+ were more likely to complete an initial FIT (67% response rate) but less likely to engage in follow-up care after an abnormal result.
- Hispanic patients were the least likely to respond to an initial FIT compared to patients who identified as White (48% vs. 61%). However, they were more likely to get follow-up care after an abnormal result.
- Patients living in rural areas were more likely to respond to an initial FIT compared to patients living in urban settings. They were also more likely to complete a colonoscopy following an abnormal FIT.
These and other findings suggest that FITs may be particularly effective for certain groups, such as older adults and patients living in rural regions.
"At-home screening programs can reduce barriers that prevent patients from getting screened for colorectal cancer," explains Sarah Roth, PhD, research scientist at CORE. "Our findings show these programs can work for many patients, but they also highlight opportunities to better engage groups historically underserved by the health care system."
As health systems continue working to boost CRC screening through at-home FITs, this research points to opportunities to ensure more patients benefit from timely screening and follow-up care.
To learn more, read the paper in Scientific Reports
Related resources





















